Collection of YouTube videos featuring Dr. Isaac Eliaz, integrative health expert.
Collection of videos featuring Dr. Isaac Eliaz on World News.
A non-toxic, botanical formula controls aggressive human prostate tumors in mice, according to a peer-reviewed study in the The International Journal of Oncology.
Scientists at Indiana University, Methodist Research Institute study a botanical formula that kills aggressive prostate cancer tumors.
Prostate cancer remains a leading cause of cancer related death for men in developed countries. One in six men will fight prostate cancer in their lifetime and in many cases this disease is aggressive and difficult to treat using conventional therapies alone. Researchers are constantly seeking safe and effective methods to halt or slow prostate cancer progression ...
Scientists at Indiana University, Methodist Research Institute, study a botanical formula that kills aggressive prostate cancer tumors. Their findings, based on experiments in mice using a human prostate cancer tumor model, appear online in The International Journal of Oncology.
Rhodes, Greece (October 12, 2011) — New animal study confirms the dramatic effects of a natural formula against aggressive prostate cancer tumors. Researchers at the Methodist Research Institute at Indiana University conducted the study on mice, using a human prostate cancer xenograft model (outlined below). These latest results have been presented to hundreds of researchers
Pomegranates are an ancient Mediterranean fruit which have recently been recognized as one of the many "new" super foods offering a myriad of health benefits. Pomegranates are rich in antioxidants, which are natural compounds that protect cells from damage caused by free radicals.
Dr. Isaac Eliaz lectures on Integrative approaches to Prostate Cancer at the American Academy of Anti-Aging Medicine (A4M) Integrative Oncology Fellowship. The fellowship, held in Boca Raton, Florida, brought together experts, and works to educate physicians and scientists on all issues related to Integrative Cancer Care.
Dr. Jun Yan, lead author, explains, "Our findings clearly demonstrate that MCP possesses anti-prostate cancer properties in both androgen-dependent (hormonal sensitive) and androgen-independent (hormonal resistant) prostate cancer cells. These results strongly suggest that MCP can be a promising chemopreventive and therapeutic agent against this malignancy."